UnitedHealthcare and Johns Hopkins Medicine end negotiations, leaving thousands of patients in Maryland to face out-of-pocket costs for care.

Doctors at Johns Hopkins Medicine hospitals and facilities have stopped taking in-network insurance from UnitedHealthcare ...

Private equity activity in gastroenterology is slowing in frequency, even as deal sizes and consolidation momentum grow. This shift is redefining the field — and what independent GI groups and ASCs ...

UnitedHealth Group Incorporated UNH is actively expanding its focus on behavioral health, one of the most rapidly growing ...

UNH stock's rare dip offers a contrarian opportunity. Buffett's $1.6B stake, industry repricing, and Optum's moat hint at ...

Johns Hopkins and UnitedHealthcare ended their insurance coverage agreement, impacting nearly 60,000 patients in the Maryland ...

For much of the past two years, U.S. markets have been dominated by a higher-for-longer rate regime. Growth stocks, particularly the tech-heavy Magnificent Seven, have thrived in this environment.

Investors have sharply different responses to UnitedHealth Group’s ongoing legal, regulatory and financial turmoil.

At roughly 12 times trailing adjusted earnings versus a three-year average of 25 times, a climb from around $300 to above ...

Come Monday, nearly 60,000 Johns Hopkins Medicine patients in the Maryland area could lose insurance coverage under ...

UnitedHealth Group’s multibillion-dollar pharmacy benefit manager, Optum Rx, is suing five Kentucky counties in an attempt to ...

Berkshire Hathaway's recent UnitedHealth investment was a 'perfect Buffett play,' one longtime follower said.